Inhibitory effect of clemastine on P-glycoprotein expression and function: an in vitro and in situ study
محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 19، شماره: 4
سال انتشار: 1395
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 184
فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-19-4_012
تاریخ نمایه سازی: 30 مهر 1400
چکیده مقاله:
Objective(s):Transporters have an important role in pharmacokinetics of drugs. Inhibition or induction of drug transporters activity can affect drug absorption, safety, and efficacy. P-glycoprotein (P-gp) is the most important membrane transporter that is responsible for active efflux of drugs. It is important to understand which drugs are substrates, inhibitors, or inducers of P-gp to minimize or avoid unwanted interactions. The aim of this study was to investigate the effects of clemastine on the expression and function of P-gp. Materials and Methods: The effect of clemastine on P-gp function and expression was evaluated in vitro byrhodamine-۱۲۳ (Rho۱۲۳) efflux assay in Caco-۲ cells and Western blot analysis. Rat in situ single pass intestinal permeability model was used to investigate the clemastine effect on digoxin Peff, as a known P-gp substrate. Digoxin levels in intestinal perfusates were assayed by high performance liquid chromatography (HPLC) method. Results:The Caco-۲ intracellular accumulation of Rho۱۲۳ in clemastine and verapamil treated cells was ۹۰.۸ ± ۹.۸ and ۴۲۰.۶±۲۵.۴ pg/mg protein, respectively which was significantly higher than that in control cells (۵۰.۲±۶.۰; P<۰.۰۵). Immunoblotting results indicated that clemastine decreased expression of P-gp in Caco-۲ cells in vitro. More over effective intestinal permeability (Peff) of digoxin in the presence of clemastine, was significantly increased compare to control group. Conclusion: Findings of our study suggested dose dependent P-gp inhibition activity for clemastine in vitro and in situ. Therefore co-administration of clemastine with P-gp substrates may result in unwanted interactions and side effects.
کلیدواژه ها:
نویسندگان
Mehran Mesgari Abbasi
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Hadi Valizadeh
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Hamed Hamishekar
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Leila Mohammadnejad
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Parvin Zakeri-Milani
Liver and Gastrointestinal Diseases Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :